NEW YORK/St. HERBLAIN – July 28th, 2015
JMC Investment LLC (“JMC”) is pleased to announce it has acquired a majority equity stake in Keosys SAS (the “Company”), a software publisher and service provider specializing in image diagnosis and image management for radiology and nuclear medicine. The Company was founded in 2001 and is based in Nantes, France.
“I’m very excited about our investment in Keosys” said Jean-Marie Painvin, Founder & CEO of JMC. “The team has developed exciting and innovative products since inception and we are poised to take the Company to the next level in the near future”.
Mr. Jerome Fortineau, Founder & CEO of Keosys added, “I am thrilled about this partnership with JMC. Our vision for the Company is aligned and JMC will bring experience that will be extremely valuable in helping Keosys execute its growth initiatives”.
Monassier & Associés (Pierre-Arnaud Conchon) served as the legal counsel to JMC Investment.
About Keosys SAS
Since its creation in 2001, Keosys has built a rich expertise in medical imaging, telecommunication and IT. Backed by a skilled, dedicated and motivated team of experts, Keosys has developed innovative products and services utilized in medical diagnosis and clinical trials. In addition, Keosys’ newest innovation, VICToria (Virtual Imaging Clinical Trials), is an exciting Big Data project providing breakthrough advantages for clinical trials, diagnosis and clinical research. The Company is headquartered in Nantes (France) with operations in the United-States and Singapore.
For more information please visit www.keosys.com